Patent · US Active

Model-based personalization scheme of an artificial pancreas for type I diabetes applications

US10413664B2 · kind B2 · utility

0Cited by

0References

12Claims

0Family size

Assignee

The Regents of the University of California · US

Inventors

Francis J. Doyle, III · Lompoc, US
Eyal Dassau · Goleta, US
Dale E. Seborg · Lompoc, US
Joon Bok LEE · Acton, US

Key dates

Filing date	Jul 6, 2015
Grant date	Sep 17, 2019
Priority date	—
Expiry date	Sep 22, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61M2205/52
WIPO fieldMedical technology
WIPO sectorInstruments

Abstract

A model-based control scheme consisting of either a proportional-integral-derivative (IMC-PID) controller or a model predictive controller (MPC), with an insulin feedback (IFB) scheme personalized based on a priori subject characteristics and comprising a lower order control-relevant model to obtain PID or MPC controller for artificial pancreas (AP) applications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.